Browse by category

Levita Magnetics has announced the world's first commercial use of its MARS platform. The first commercial use, which took place in...

GE HealthCare has gained FDA 510(k) clearance of the Allia IGS Pulse - the latest addition to the company’s image guided system (IGS)...

Novo Nordisk is ending its Phase III FLOW trial ahead of schedule after an interim analysis of the kidney outcomes study of semaglutide...

Allurion Technologies has completed patient enrolment in its AUDACITY trial, a randomised, pivotal controlled trial designed to support...

The first participant has been dosed in MBX Biosciences’ Phase 1/2 clinical trial of MBX 1416, the company’s long-acting glucagon-like...

Boehringer Ingelheim and Zealand Pharma have initiated three Phase III trials investigating survodutide (also known as BI 456906) for...

The first patient has been treated with Sigrid Therapeutics’ SiPore21, an innovative medical device designed for sustained diabetes and...

The European Medicines Agency (EMA) will assess the risk that patients on weight loss drugs such as semaglutide and tirzepatide may...

ReShape Lifesciences has signed an exclusive, royalty-bearing license agreement with Biorad Medysis (Biorad) to manufacture,...

ReShape Lifesciences has strengthened the patent portfolio related to its Obalon Balloon System, after to US Patent and Trademark Office...